SPLG vs XLV
SPDR Portfolio S&P 500 ETF vs Health Care Select Sector SPDR Fund
- • SPLG has the lower expense ratio at 0.02% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.60%).
Side-by-side metrics
| Metric | SPLG | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.02% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.13% | 1.60% |
AUM Assets under management — bigger funds are typically more liquid. | $97.33B | $40.60B |
YTD return | 17.45% | 5.74% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 0.51 |
P/E ratio | 27.43 | 29.18 |
Last price | $80.00 | $162.17 |
Inception | — | — |
Issuer | State Street | State Street |
SPLG top holdings
| NVDA | NVIDIA Corp | 7.38% |
| AAPL | Apple Inc | 7.07% |
| MSFT | Microsoft Corp | 6.25% |
| AMZN | Amazon.com Inc | 3.87% |
| AVGO | Broadcom Inc | 3.24% |
| GOOGL | Alphabet Inc Class A | 3.18% |
| GOOG | Alphabet Inc Class C | 2.55% |
| META | Meta Platforms Inc Class A | 2.40% |
| TSLA | Tesla Inc | 2.06% |
| BRK-B | Berkshire Hathaway Inc Class B | 1.61% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.48% |
| JNJ | Johnson & Johnson | 10.62% |
| ABBV | AbbVie Inc | 7.72% |
| UNH | UnitedHealth Group Inc | 6.56% |
| MRK | Merck & Co Inc | 5.51% |
| AMGN | Amgen Inc | 3.40% |
| TMO | Thermo Fisher Scientific Inc | 3.24% |
| ABT | Abbott Laboratories | 2.75% |
| GILD | Gilead Sciences Inc | 2.73% |
| ISRG | Intuitive Surgical Inc | 2.45% |
About SPLG
SPLG (SPDR Portfolio S&P 500 ETF) is Low-cost State Street S&P 500 ETF. Managed by State Street, the fund carries $97.3B in assets under management, an expense ratio of 0.02%, a dividend yield of 1.13%. Its largest holding is NVIDIA Corp (NVDA), which represents 7.4% of the portfolio. Real Estate is the fund's largest sector exposure at 1.9%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $40.6B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.60%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.5% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.